Molecular Docking and Dynamic Simulation to Identify α7nAChR Binding Affinity of Flavonoids for the Treatment of Alzheimer's Disease.

Abstract

Alpha-7-nicotinic acetylcholine receptor (α7nAChR), a ligand-gated ion channel is one of the important parts of the cholinergic pathway in the brain and has a remarkable role in Alzheimer's disease. It has been documented that the modulation of α7nAChR with the help of phytoconstituent can be helpful in the treatment of AD. The binding efficacy of fifty flavonoids was evaluated for human α7nAChR using molecular docking. The best two flavonoids shortlisted from docking analysis were then subjected to molecular dynamic simulations for 100ns to analyze conformational binding stability with the target protein. Further, the druggability of the selected flavonoids was checked using in silico ADMET studies. The top two flavonoids selected based on binding affinity toward the binding site of α7nAChR from molecular docking were amentoflavone and gallocatechin. The molecular dynamics simulation revealed that amentoflavone and gallocatechin have a stable state during overall simulation time, lesser RMSD and RMSF, and complex of both compounds with protein is stable until 100ns. The two flavonoids amentoflavone and gallocatechin are potential lead molecules that could be utilized as effective agonists of α7nAChR to combat Alzheimer's disease. Future in vitro and in vivo analyses are required to confirm their effectiveness.